This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Aug;4(2):93-105.

Protein kinase C--a novel target for rational anti-cancer drug design?

A Gescher¹, I L Dale

Affiliations

PMID: 2679620

Review

Protein kinase C--a novel target for rational anti-cancer drug design?

A Gescher et al. Anticancer Drug Des. 1989 Aug.

. 1989 Aug;4(2):93-105.

Authors

A Gescher¹, I L Dale

Affiliation

¹ Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.

PMID: 2679620

No abstract available

PubMed Disclaimer

Similar articles

Combination chemotherapy--theory and practice.
Capizzi RL, Keiser LW, Sartorelli AC. Capizzi RL, et al. Semin Oncol. 1977 Jun;4(2):227-53. Semin Oncol. 1977. PMID: 327555 Review. No abstract available.
In search of novel molecular targets in cancer: the diacyglycerol pathways.
Lorenzo PS. Lorenzo PS. Hawaii Med J. 2004 Oct;63(10):318-9, 321. Hawaii Med J. 2004. PMID: 15570721 Review. No abstract available.
The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A, Ackland SP, Gardiner E, Walkom CC, Sakoff JA. McCluskey A, et al. Anticancer Drug Des. 2001 Dec;16(6):291-303. Anticancer Drug Des. 2001. PMID: 12375882
[Protein kinase C. Key enzyme for immune reactions and cell growth].
Hellwiq B. Hellwiq B. Med Monatsschr Pharm. 1994 Nov;17(11):326-8. Med Monatsschr Pharm. 1994. PMID: 7823874 Review. German. No abstract available.
The place of pharmacology in cancer medicine.
Capizzi RL. Capizzi RL. Semin Oncol. 1977 Jun;4(2):131-3. Semin Oncol. 1977. PMID: 877598 No abstract available.

See all similar articles

Cited by

Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.
Dean NM, McKay R. Dean NM, et al. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11762-6. doi: 10.1073/pnas.91.24.11762. Proc Natl Acad Sci U S A. 1994. PMID: 7972137 Free PMC article.
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.
Brunton VG, Workman P. Brunton VG, et al. Br J Cancer. 1993 May;67(5):989-95. doi: 10.1038/bjc.1993.181. Br J Cancer. 1993. PMID: 8388233 Free PMC article.
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies.
Eder JP Jr, Garcia-Carbonero R, Clark JW, Supko JG, Puchalski TA, Ryan DP, Deluca P, Wozniak A, Campbell A, Rothermel J, LoRusso P. Eder JP Jr, et al. Invest New Drugs. 2004 Apr;22(2):139-50. doi: 10.1023/B:DRUG.0000011790.31292.ef. Invest New Drugs. 2004. PMID: 14739662 Clinical Trial.
Protein kinase C targeting in antineoplastic treatment strategies.
Jarvis WD, Grant S. Jarvis WD, et al. Invest New Drugs. 1999;17(3):227-40. doi: 10.1023/a:1006328303451. Invest New Drugs. 1999. PMID: 10665476 Review.
Isolation and characterization of a novel zinc finger gene, ZNFD, activating AP1(PMA) transcriptional activities.
Lei C, Liu Q, Wang W, Li J, Xu F, Liu Y, Liu J, Wu S, Wang M. Lei C, et al. Mol Cell Biochem. 2010 Jul;340(1-2):63-71. doi: 10.1007/s11010-010-0401-1. Epub 2010 Feb 18. Mol Cell Biochem. 2010. PMID: 20162441

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database